Assure to Attend Investor Conferences in December 2022

Rhea-AI Summary

Assure Holdings Corp. (NASDAQ: IONM) announced its participation in two investor conferences in December 2022. Management will engage in one-on-one meetings at the Benchmark Discovery One-on-One Investor Conference on December 1 and the Roth Capital Deer Valley Conference on December 15-16. Assure specializes in intraoperative neuromonitoring and remote neurology services, providing clinical support during high-risk surgeries. The company emphasizes patient safety and real-time monitoring during procedures, aiming to deliver exceptional surgical care.

DENVER, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced that management will participate in the following investor conferences in December 2022:

• The Benchmark Discovery One-on-One Investor Conference on December 1, 2022. The conference offers emerging growth and dynamic publicly traded companies access to institutions and individuals in a unique one-on-one format. Assure management will participate in one-on-one meetings with prospective investors and other interested parties.
• Roth Capital Deer Valley Conference on December 15-16, 2022. This invitation only event provides a forum for public companies to tell their stories to investors. One-on-one and group meetings will be held throughout the conference.

Neither of these events include central presentations.

About Assure Holdings
Assure Holdings Corp. is a best-in-class provider of outsourced intraoperative neuromonitoring and remote neurology services. The Company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that place the nervous system at risk including neurosurgery, spine, cardiovascular, orthopedic and ear, nose and throat surgeries. Assure employs highly trained technologists that provide a direct point of contact in the operating room. Physicians employed through Assure subsidiaries simultaneously monitor the functional integrity of patients’ neural structures throughout the procedure communicating in real-time with the surgeon and technologist. Accredited by The Joint Commission, Assure’s mission is to provide exceptional surgical care and a positive patient experience. For more information, visit the company’s website at www.assureneuromonitoring.com.

Forward-Looking Statements
This news release may contain “forward-looking statements” within the meaning of applicable securities laws, including, but not limited to comments with respect to: expectations with respect to the Company’s growth and development and the quality and results of future services. Forward-looking statements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to: the uncertainty surrounding the spread of COVID-19 and the impact it will have on the Company’s operations and business, its remote neurology business, and economic activity in general; and risks and uncertainties discussed in our most recent annual and quarterly reports filed with the United States Securities and Exchange Commission, including our annual report on Form 10-K filed on March 14, 2022, and available on the Company’s EDGAR profile at www.sec.gov, which risks and uncertainties are incorporated herein by reference. Except as required by law, Assure does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.

Contact
Scott Kozak, Investor and Media Relations
Assure Holdings Corp.
1-720-617-2526
Scott.Kozak@assureiom.com

FAQ

What investor conferences will Assure Holdings participate in December 2022?

Assure Holdings will participate in the Benchmark Discovery One-on-One Investor Conference on December 1 and the Roth Capital Deer Valley Conference on December 15-16, 2022.

What services does Assure Holdings provide?

Assure Holdings offers intraoperative neuromonitoring and remote neurology services, supporting surgeons during high-risk procedures.

What is the stock symbol for Assure Holdings?

The stock symbol for Assure Holdings is IONM.

What type of meetings will Assure Holdings have at the investor conferences?

Assure Holdings will hold one-on-one meetings with prospective investors and interested parties at both conferences.

What is the mission of Assure Holdings?

Assure Holdings aims to provide exceptional surgical care and a positive patient experience while ensuring the functional integrity of patients’ neural structures during surgeries.